Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia

Stephen E. Kurtz, Christopher A. Eide, Andy Kaempf, Motomi Mori, Cristina E. Tognon, Uma Borate, Brian J. Druker, Jeffrey W. Tyner

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia'. Together they form a unique fingerprint.